Labels

Wednesday, February 4, 2015

FDA Approves New Breast Cancer Drug

Ibrance is targeted for postmenopausal women with advanced disease



from WebMD Health http://ift.tt/1xjzLlg

via IFTTT

No comments:

Post a Comment